Pivot Park was launched in February 2012 as an initiative of pharmaceutical company MSD in close collaboration with five partners: the province of Noord-Brabant, the municipality of Oss, the Ministry of Economic Affairs, the Ministry of Health, Welfare and Sport, and the Brabant Development Agency (BOM). The province of Noord-Brabant is Pivot Park’s shareholder.

Pivot Park is located at the Moleneind site in Oss and therefore boasts a long tradition of drug development. This is where Organon started up in 1923, so the focus on medication and innovation at the site dates back nearly a century. Building on the available facilities, knowledge and experience, Pivot Park is adding a new chapter to this illustrious tradition.